Netherlands' Corbion Q3 revenue rises year-on-year, maintains 2026 outlook

Overview

• Netherlands sustainable ingredients firm's Q3 revenue rose 9.3% yr/yr, organic sales up 7.6%

• Q3 adjusted EBITDA grew 29% yr/yr, margin improved to 18.8%

• Company discontinued PLA divestment process after offers did not reflect business value

Outlook

• Corbion maintains full-year 2026 guidance

• Company says visibility into Q4 orderbook supports maintained 2026 outlook

• Company sees ongoing cost-reduction initiatives and operational efficiencies supporting margins

Result Drivers

• VOLUME/MIX GROWTH - Co said organic sales growth was driven by positive volume/mix development, especially in Health & Nutrition

• OMEGA-3 DHA PRICES - Higher fish oil prices led to increased omega-3 DHA prices, positively impacting Health & Nutrition volume/mix

• COST REDUCTION & EFFICIENCY - Adjusted EBITDA margin improvement attributed to cost-reduction initiatives and operational efficiencies

Company press release:

Key Details

Analyst Coverage

• The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

• The average consensus recommendation for the specialty chemicals peer group is "buy"

• Wall Street's median 12-month price target for Corbion NV is €25.50, about 6.2% below its October 27 closing price of €27.20

• The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 14 three months ago

Reuters Recommended Reads

• Oct 27 - French glass packaging firm Verallia's Q3 revenue falls on lower volumes

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)